DKK1 and lung carcinoma: In recent years, publications have demonstrated that increased concentrations of DKK‐1 could be specifically measured in serologic samples from patients with diverse malignancies like pancreas cancer, stomach cancer, liver cancer, breast cancer, lung cancer, and so on 7, 8, 9.